Kynurenic acid, an endogenous constituent of rheumatoid arthritis synovial fluid, inhibits proliferation of synoviocytes in vitro

Rheumatology International

Volumn 26, Issue 5, 2006, Pages 422-426

  Parada Turska, Jolanta ^a   Rzeski, Wojciech ^b,c   Zgrajka, Wojciech ^c   Majdan, Maria ^a   Kandefer Szerszeń, Martyna ^b   Turski, Waldemar ^a,c  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^c INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Kynurenic acid; Rheumatoid arthritis; Synovial fluid; Synoviocytes

Indexed keywords

CELECOXIB; KYNURENIC ACID; NIMESULIDE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IC 50; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL; SYNOVIOCYTE;

ANIMALS; ARTHRITIS, RHEUMATOID; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; HUMANS; KNEE JOINT; KYNURENIC ACID; MALE; RABBITS; SYNOVIAL FLUID;

EID: 33644630736     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-005-0057-4     Document Type: Article

References (32)

1. Ospelt C, Neidhart M, Gay RE, Gay S (2004) Synovial activation in rheumatoid arthritis. Front Biosci 9:2323-2334
2. Kramer I, Wibulswas A, Croft D, Genot E (2003) Rheumatoid arthritis: targeting the proliferative fibroblasts. Prog Cell Cycle Res 5:59-70
3. Ritchlin C (2000) Fibroblasts biology. Effector signals released by the synovial fibroblasts in arthritis. Arthritis Res 2:356-360
4. Qu Z, Garcia CH, O'Rourke LM, Planck SR, Kohli M, Rosenbaum JT (1994) Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc and nucleolar organizer region staining. Arthritis Rheum 37:212-220
5. Kurowska M, Rudnicka W, Kontny E, Janicka I, Chorazy M, Kowalczewski J, Ziolkowska M, Ferrari-Lacraz S, Strom TB, Maslinski W (2002) Fibroblast-like synoviocytes from rheumatoid arthritis patients express functional IL-15 receptor complex: endogenous IL-15 in autocrine fashion enhances cell proliferation and expression of Bcl-x(L) and Bcl-2. J Immunol 169:1760-1767
6. Lacey D, Sampey A, Mitchell R, Bucala R, Santos L, Leech M, Morand E (2003) Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthritis Rheum 48:103-109
7. Ganong AH, Lanthorn TH, Cotman CW (1983) Kynurenic acid inhibits synaptic and amino acid-induced responses in the rat hippocampus and spinal cord. Brain Res 273:170-174
8. Birch PJ, Grossman CJ, Hayes AG (1988) Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor. Eur J Pharmacol 154:85-87
9. Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX (2001) The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci 21:7463-7473
10. Milart P, Urbańska EM, Turski WA, Paszkowski T, Sikorski R (1999) Intrapartum levels of endogenous glutamate antagonist - kynurenic acid in amniotic fluid, umbilical and maternal blood. Neurosci Res Com 24:173-178
11. Swartz KJ, Matson WR, MacGarvey U, Ryan EA, Beal MF (1990) Measurement of kynurenic acid in mammalian brain extracts and cerebrospinal fluid by high-performance liquid chromatography with fluorometric and coulometric electrode array detection. Anal Biochem 1990:363-376
12. Turski WA, Nakamura M, Todd WP, Carpenter BK, Whetsell WO Jr, Schwarcz R (1988) Identification and quantification of kynurenic acid in human brain tissue. Brain Res 454:164-169
13. Rejdak R, Zarnowski T, Turski WA, Kocki T, Zagorski Z, Zrenner E, Schuettauf F (2003) Alteriations of kynurenic acid content in the retina in response to retinal ganglion cell damage. Vision Res 43:497-503
14. Foster AC, Vezzani A, French ED, Schwarcz R (1984) Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid. Neurosci Lett 48:273-278
15. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, Olney JW (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283:70-74
16. Rzeski W, Ikonomidou C, Turski L (2002) Glutamate antagonists limit tumor growth. Biochem Pharmacol 64:1195-2000
17. Rzeski W, Turski L Ikonomidou C (2001) Glutamate antagonists limit tumor growth. Proc Natl Acad Sci USA 98:6372-6377
18. Litchfield JT, Wilcoxon FA (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99-113
19. Igari T, Tsuchizawa M, Obara K, Ono S (1969) Tryptophan metabolizm in the synovial fluid in rheumatoid arthritis and osteoarthritis. Tohoku J Exp Med 99:73-80
20. Schwarcz R, Pellicciari R (2002) Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther 303:1-10
21. Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M, Dilling LA, Elia J, Kruesi MJ, Lackner A (1992) Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 115:1249-73
22. Bertazzo A, Punzi L, Bertazzolo N, Pianon M, Pozzuoli A, Costa CV, Allegri G (1999) Tryptophan catabolism in synovial fluid of various arthropathies and its relationship with inflammatory cytokines. Adv Exp Med Biol 467:565-70
23. Forrest CM, Kennedy A, Stone TW, Stoy N, Darlington LG (2003) Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment. Adv Exp Med Biol 527:287-295
24. Schroecksnadel K, Kaser S, Ledochowski M, Neurauter G, Mur E, Herold M, Fuchs D (2003) Increased degradation of tryptophan in blood of patients with rheumatoid arthritis. J Rheumatol 30:1935-1939
25. McNearney T, Speegle D, Lawand N, Lisse J, Westlund KN (2000) Excitatory amino acid profiles of synovial fluid from patients with arthritis. J Rheum 27:739-745
26. Lawand NB, McNearney T, Westlund KN (2000) Amino acid release into the knee joint: key role in nociception and inflammation. Pain 86:69-74
27. Sluka KA, Jordan HH, Willis WD, Westlund KN (1994) Differential effects of N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists on spinal release of amino acids after development of acute arthritis in rats. Brain Res 664:77-84
28. Kristensen JD, Post C, Gordh T Jr, Svensson BA (1993) Spinal cord morphology and antinociception after chronic intrathecal administration of excitatory amino acid antagonists in the rat. Pain 54:309-316
29. Kusunoki N, Yamazaki R, Kawai S (2002) Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors. Arthritis Rheum 46:3159-3167
30. Yamazaki R, Kusunoki N, Matsuzaki T, Hashimoto S, Kawai S (2002) Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells. FEBS Lett 531:278-284
31. Wu GS, Zou SQ, Liu ZR, Tang ZH, Wang JH (2003) Celecoxib inhibits proliferation and induces apoptosis via prostaglandin E2 pathway in human cholangiocarcinoma cell lines. World J Gastroenterol 9:1302-1306
32. Eibl G, Reber HA, Wente MN, Hines OJ (2003) The selective cyclooxygenase-2 inhibitor nimesulide induces apoptosis in pancreatic cancer cells independent of COX-2. Pancreas 26:33-41